Corvus Pharmaceuticals, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol: CRVS on Nasdaq
Industry: Pharmaceutical Preparations
Location: 863 Mitten Road, Suite 102, Burlingame, CA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	4	+3.49M	100%	$1.73	+$6.03M
Sells	0
Net	+4	+3.49M	100%		+$6.03M

Corvus Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Peter A. Thompson	Director, 10%+ Owner	$14.5M	+$2.5M	+20.8%	Jun 13, 2024
Terry P. Gould	Director, 10%+ Owner	$5.67M			Jun 13, 2024
Richard A. Miller	President and CEO, Director	$3.06M	+$1M	+48.6%	May 10, 2024
Adams Street Partners Llc	10%+ Owner	$2.59M			Aug 11, 2022
Orbimed Advisors Llc	Director, 10%+ Owner	$2.5M	+$2.5M		May 6, 2024
William Benton Jones	SVP, Pharmaceutical Development	$266K	+$34.6K	+15%	May 6, 2024
Leiv Lea	Chief Financial Officer	$223K			Dec 6, 2023
EcoR1 Capital, LLC	10%+ Owner	$64.1K			Sep 30, 2021
Linda Grais	Director				Jun 13, 2024
Scott W. Morrison	Director				Jun 13, 2024
Ian T. Clark	Director				Jun 13, 2024
Edith P. Mitchell	Director				Dec 6, 2023
Jeffrey Arcara	Chief Business Officer				Feb 28, 2024

Recent Insider Transactions by Companies or Individuals for Corvus Pharmaceuticals, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.